Jean-Michel Scherrmann

Title: The Innovations of Jean-Michel Scherrmann

Introduction

Jean-Michel Scherrmann is a notable inventor based in Enghien les Bains, France. He has made significant contributions to the field of drug abuse sciences, particularly in the development of immunogens and antibodies related to cocaine treatment. With a total of 3 patents, his work has the potential to impact medical practices significantly.

Latest Patents

One of his latest patents involves the creation of cocaethylene immunogens and antibodies. This patent describes the ethyl ester of derivatives of benzoyl ecgonine, which are designed with a linking group at the para position of the benzoyl group. These derivatives are utilized to bond with immunogenic polypeptides, facilitating the production of antisera and monoclonal antibodies. The resulting antisera and antibodies are intended for use in assays, as well as for the treatment of cocaine overdose and detoxification.

Career Highlights

Jean-Michel Scherrmann is associated with Drugabuse Sciences, Inc., where he continues to innovate in the field of drug abuse treatment. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Philippe J Pouletty and Herve Galons, contributing to a dynamic research environment focused on drug abuse sciences.

Conclusion

Jean-Michel Scherrmann's contributions to the field of immunology and drug treatment exemplify the impact of innovative thinking in medicine. His patents and ongoing work continue to pave the way for advancements in the treatment of drug-related issues.